This new eight-episode educational video series will examine the latest efforts to respond to the COVID-19 pandemic and break down the complex process of developing a vaccine.
Each week our host Lisa Ling will talk to leading scientists and researchers, healthcare workers on the front lines and public health experts around the world working collaboratively to help bring an end to the deadly pandemic.
It took a pandemic to break down barriers to innovation. Is this wave of ingenuity here to stay?
Article
No individual, industry, or country was ready for coronavirus. Traditional systems continue to buckle under the strains of disruption, forcing years of change in a matter of months. Every day, doctors and nurses don their armor of latex, plexiglass, and cotton. They're backed by supporters big and small: from manufacturing and healthcare companies to parents-turned-mask-makers, and 3D printing entrepreneurs.
By John Sayre, Senior Vice President of Development Operations at Gilead
Blog
When I was in college, I learned about the Spanish Flu in a class on the history of medicine. I found the pandemic so fascinating that I reached out to my grandmother Cordelia to ask her about it. She was about 80 by then but still remembered it vividly. She described driving through a neighborhood in Akron, Ohio at the age of 15 and seeing people throwing furniture out of an attic window. Everyone in the house had died, and they were burning everything inside to kill the germs.
This new eight-episode educational video series will examine the latest efforts to respond to the COVID-19 pandemic and break down the complex process of developing a vaccine.
Each week our host Lisa Ling will talk to leading scientists and researchers, healthcare workers on the front lines and public health experts around the world working collaboratively to help bring an end to the deadly pandemic.
The online learning program combines lab simulations and mentoring experiences focused on biotechnology and neurological diseases, such as Parkinson’s disease, Alzheimer’s disease and multiple sclerosis
Four hundred students from Massachusetts and North Carolina are enrolling in this no-fee program that also provides students with computers and other technology resources
The initiative builds upon Biogen’s Community Lab, which has enrolled more than 55,000 students to date, and the Lemelson-MIT Program in inspiring the next generation of creative and inventive problem solvers
Press Release
The online learning program combines lab simulations and mentoring experiences focused on biotechnology and neurological diseases, such as Parkinson’s disease, Alzheimer’s disease and multiple sclerosis
Four hundred students from Massachusetts and North Carolina are enrolling in this no-fee program that also provides students with computers and other technology resources
The initiative builds upon Biogen’s Community Lab, which has enrolled more than 55,000 students to date, and the Lemelson-MIT Program in inspiring the next generation of creative and inventive problem solvers
This new eight-episode educational video series will examine the latest efforts to respond to the COVID-19 pandemic and break down the complex process of developing a vaccine.
Each week our host Lisa Ling will talk to leading scientists and researchers, healthcare workers on the front lines and public health experts around the world working collaboratively to help bring an end to the deadly pandemic.
Scientists at the facility, opening in the nation's capital this year, will be focused on advancing breakthrough ideas for safeguarding people around the world from pandemics like Covid-19, infectious diseases and other health threats.
Blog
It was a year ago this month that Johnson & Johnson Innovation first unveiled plans to launch a healthcare innovation facility in Washington, D.C., in collaboration with BARDA—also known as the Biomedical Advanced Research and Development Authority, a component of the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services.
Investing in promising new pharmaceutical platforms like oligonucleotide therapies could reduce the gap between first detection and total eradication in future pandemics.
This new eight-episode educational video series will examine the latest efforts to respond to the COVID-19 pandemic and break down the complex process of developing a vaccine.
Each week our host Lisa Ling will talk to leading scientists and researchers, healthcare workers on the front lines and public health experts around the world working collaboratively to help bring an end to the deadly pandemic.
